Highland Capital Management (Texas)’s ANI Pharmaceuticals ANIP Stock Holding History

Highland Capital Management (Texas)’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$584K	Hold	7,100	–	–	0.03%	243
2019 Q1	$501K	Hold	7,100	–	–	0.03%	242
2018 Q4	$320K	Sell	7,100 -1,900	-21%	-$99.6K	0.02%	227
2018 Q3	$509K	Hold	9,000	–	–	0.03%	220
2018 Q2	$601K	Buy	9,000 +4,600	+105%	+$287K	0.03%	197
2018 Q1	$256K	Hold	4,400	–	–	0.01%	303
2017 Q4	$284K	Sell	4,400 -1,600	-27%	-$99.5K	0.01%	271
2017 Q3	$315K	Buy	6,000 +1,150	+24%	+$54.8K	0.01%	249
2017 Q2	$227K	Hold	4,850	–	–	0.01%	271
2017 Q1	$240K	Buy	+4,850	New	+$272K	0.01%	266

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Highland Capital Management (Texas)'s ANIP Position: Q2 2019 in Review

Highland Capital Management (Texas) held its ANI Pharmaceuticals (ANIP) position steady in Q2 2019 at 7,100 shares worth $584K. The position accounts for 0.03% of the portfolio, ranked #243.

Highland Capital Management (Texas) first reported a position in ANIP in Q1 2017 and has held it in 10 quarters since. The position peaked at $601K in Q2 2018. 196 funds tracked by Wall St. Rank hold ANIP as of Q2 2019.

Highland Capital Management (Texas) held 7,100 shares of ANI Pharmaceuticals worth $584K as of Q2 2019.
Highland Capital Management (Texas) left its ANI Pharmaceuticals share count unchanged in Q2 2019.
ANI Pharmaceuticals made up 0.03% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #243 holding.
Highland Capital Management (Texas) first reported a position in ANI Pharmaceuticals in Q1 2017 and has held it in 10 quarters since.
Highland Capital Management (Texas)'s ANI Pharmaceuticals position peaked at $601K in Q2 2018.
196 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.